{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T19:50:09Z","timestamp":1771789809872,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1111\/bjd.14976","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T11:34:48Z","timestamp":1471520088000},"page":"1048-1055","source":"Crossref","is-referenced-by-count":39,"title":["High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics"],"prefix":"10.1093","volume":"176","author":[{"given":"N.","family":"Desai","sequence":"first","affiliation":[{"name":"St John's Institute of Dermatology; Guy's and St Thomas' Hospital NHS Foundation Trust; London SE1 7EH U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Shah","sequence":"additional","affiliation":[{"name":"AbbVie Limited; Maidenhead U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"10.1111\/bjd.14976-BIB0001|bjd14976-cit-0001","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14976-BIB0002|bjd14976-cit-0002","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1365-2230.1996.tb00145.x","article-title":"Hidradenitis suppurativa - characteristics and consequences","volume":"21","author":"Jemec","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.14976-BIB0003|bjd14976-cit-0003","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.yadr.2007.07.001","article-title":"Hidradenitis suppurativa: an update","volume":"23","author":"Lee","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1111\/bjd.14976-BIB0004|bjd14976-cit-0004","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/bjd.13270","article-title":"Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14976-BIB0005|bjd14976-cit-0005","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14976-BIB0006|bjd14976-cit-0006","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jaad.2014.11.017","article-title":"Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement","volume":"72","author":"Deckers","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14976-BIB0007|bjd14976-cit-0007","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa)","volume":"2","author":"Fimmel","year":"2010","journal-title":"Dermatoendocrinol"},{"key":"10.1111\/bjd.14976-BIB0008|bjd14976-cit-0008","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/QCO.0b013e3283428d07","article-title":"Hidradenitis suppurativa: a review of cause and treatment","volume":"24","author":"Yazdanyar","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/bjd.14976-BIB0009|bjd14976-cit-0009","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14976-BIB0010|bjd14976-cit-0010","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14976-BIB0011|bjd14976-cit-0011","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/bjd.12104","article-title":"Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review","volume":"168","author":"Blok","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14976-BIB0012|bjd14976-cit-0012","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14976-BIB0013|bjd14976-cit-0013","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2340\/00015555-0747","article-title":"Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors","volume":"89","author":"Haslund","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.14976-BIB0014|bjd14976-cit-0014","doi-asserted-by":"publisher","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1111\/bjd.14976-BIB0015|bjd14976-cit-0015","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1365-4632.2010.04545.x","article-title":"A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa","volume":"49","author":"Amano","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.14976-BIB0016|bjd14976-cit-0016","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14976-BIB0017|bjd14976-cit-0017","first-page":"s15","article-title":"A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa","volume":"11","author":"Sotiriou","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.14976-BIB0018|bjd14976-cit-0018","doi-asserted-by":"publisher","first-page":"240","DOI":"10.7150\/ijms.7.240","article-title":"Surgical management of hidradenitis suppurativa","volume":"7","author":"Menderes","year":"2010","journal-title":"Int J Med Sci"},{"key":"10.1111\/bjd.14976-BIB0019|bjd14976-cit-0019","first-page":"743","article-title":"Depression is a frequent co-morbidity in patients with acne inversa","volume":"11","author":"Kurek","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.14976-BIB0020|bjd14976-cit-0020","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","article-title":"Hidradenitis suppurativa markedly decreases quality of life and professional activity","volume":"62","author":"Matusiak","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14976-BIB0021|bjd14976-cit-0021","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14976-BIB0022|bjd14976-cit-0022","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14976-BIB0023|bjd14976-cit-0023","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.14976-BIB0024|bjd14976-cit-0024","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14976-BIB0025|bjd14976-cit-0025","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.14976-BIB0026|bjd14976-cit-0026","unstructured":"Health and Social Care Information Centre Hospital Episode Statistics http:\/\/www.hscic.gov.uk\/hes"},{"key":"10.1111\/bjd.14976-BIB0027|bjd14976-cit-0027","unstructured":"Health and Social Care Information Centre Hospital Episode Statistics. The processing cycle and HES data quality http:\/\/www.hscic.gov.uk\/article\/1825\/The-processing-cycle-and-HES-data-quality"},{"key":"10.1111\/bjd.14976-BIB0028|bjd14976-cit-0028","doi-asserted-by":"publisher","first-page":"e001651","DOI":"10.1136\/bmjopen-2012-001651","article-title":"Hospital episode statistics: improving the quality and value of hospital data: a national internet e-survey of hospital consultants","volume":"2","author":"Spencer","year":"2012","journal-title":"BMJ Open"},{"key":"10.1111\/bjd.14976-BIB0029|bjd14976-cit-0029","unstructured":"Department of Health National schedule of reference costs 2012-2013: the main schedule https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/260405\/2012-13_national_schedule_of_reference_costs.xls"},{"key":"10.1111\/bjd.14976-BIB0030|bjd14976-cit-0030","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.14976-BIB0031|bjd14976-cit-0031","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/jamadermatol.2014.691","article-title":"Health care utilization patterns and costs for patients with hidradenitis suppurativa","volume":"150","author":"Kirby","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.14976-BIB0032|bjd14976-cit-0032","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1365-2133.2010.09944.x","article-title":"A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis","volume":"163","author":"Fonia","year":"2010","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14976","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14976","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14976\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:23:04Z","timestamp":1676384584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/176\/4\/1048\/6748021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14976","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,21]]}}}